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a  b  s  t  r  a  c  t
Many  European  governments  have  abundantly  cut down  public  expenditure  on health  dur-
ing the  ﬁnancial  crisis.  Consequences  of  the  ﬁnancial  downturn  on  health  outcomes  have
begun  to  emerge.  This  recession  has  led to an  increase  in poor health  status,  raising  rates
of anxiety  and  depression  among  the  economically  vulnerable.  In  addition,  the  incidence
of  some  communicable  diseases  along  with  the  rate  of  suicide  has  increased  signiﬁcantly.
The  recession  has also  driven  structural  reforms,  and  affected  the  priority  given  to  public
policies. The  purpose  of  this  paper  is to analyse  how  austerity  impacts  health  in  Europe  and
better understand  the response  of European  health  systems  to  the ﬁnancial  crisis.
The  current  economic  climate,  while  challenging,  presents  an  opportunity  for reforming
and  restructuring  health  promotion  actions.  More  innovative  approaches  to  health  should
be developed  by  health  professionals  and  by  those  responsible  for health  management.  In
addition,  scientists  and  experts  in public  health  should  promote  evidence-based  approaches
to  economic  and  public  health  recovery  by  analyzing  the  present  economic  downturn  and
previous crisis.  However,  it is governance  and  leadership  that  will mostly  determine  how
well health  systems  are  prepared  to  face  the  crisis  and  ﬁnd  ways  to mitigate  its  effects.
hors. P© 2013 The Aut
. Introduction
The economic downturn has affected much of Europe
everely. In 2009 real gross domestic product (GDP) growth
ate fell in European Union Member States with a mean
ecrease of 4.3% [1]. In parallel, unemployment increased
onsiderably from 7.2% in 2007 to 11% in July 2013,
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although unemployment rates have varied widely from
lows of 4.8% and 5.3% in Austria and Germany, to 26.3%
and 27.6% in Spain and Greece respectively [1]. Because of
the European sovereign-debt crisis, many European Union
Member States have adopted harsh austerity policies and
have substantially cut down in public expenditure. Growth
in health spending per capita fell in real terms in 2010 in
almost all European countries, reversing a trend of steady
increases. Namely, from an annual average growth rate
of 4.6% per year between 2000 and 2009, towards a fall
in health spending per capita of 0.6% in 2010 [2]. As a
result of the downturn in health spending in 2010, the per-
centage of GDP devoted to health stabilised or declined
slightly in many EU Member States. Nonetheless in 2010,
Open access under CC BY-NC-ND license.European Union Member States devoted on average 9.0%
of their GDP to health spending, up signiﬁcantly from
7.3% in 2000, but down slightly from the peak of 9.2%
in 2009 [3].
r CC BY-NC-ND license.
lth Polic14 G. Quaglio et al. / Hea
The consequences of the economic crisis on health have
not been overlooked within various non-governmental
institutions and by many policy makers throughout the
world. For example, the World Health Organisation (WHO)
identiﬁed the importance of awareness of the risks for
health and health systems, but also the opportunities for
action that the crisis entails by introducing a resolution
in 2009 which invites European Union Member States
to ensure that their health systems continue to demon-
strate effectiveness, and to act as wise economic actors
in terms of investment, expenditure and employment [4].
Furthermore, the WHO  has recently noted the diversity in
health policies being pursued by EU Member States fol-
lowing the onset of the ﬁnancial crisis [5]. The economic
downturn receives a lot of attention within the European
Institutions. The European Parliament has appointed a new
speciﬁc committee (CRIS Committee) in order to analyse
the causes and consequences of the current crisis, the costs
of inaction, and possible ways to overcome the crisis and to
prevent any repeat [6]. In addition, recently the Council of
the European Union invited Member States and the Euro-
pean Commission to reﬂect on effective ways to invest in
health. Therefore, different working groups have been set
up to issue a response, working on an effective use of struc-
tural funds, on cost-effective use of medicines, integrated
care and hospital management and monitoring the effec-
tiveness of health investment in the European Union [7].
Another example of the attention to austerity and health
by the European Institutions has been given by STOA, the
Science and Technology Options Assessment body of the
European Parliament. In collaboration with the European
Observatory on Health Systems and Policies, – an inter-
national partnership hosted by the WHO  Regional Ofﬁce
for Europe – STOA organised a workshop to analyse the
role of evidence in promoting and strengthening public
health against the economic crisis [8–11]. The economic
downturn has raised major concerns that the function
of health systems in different European Union countries
could be compromised by reduced health budgets. How-
ever, it is necessary to note that some studies, primarily
carried out by economists in high-income countries, ﬁnd
that health conditions may  improve rather than decline
in economic downturns. Recession might improve health
at least in the short run, because it is associated with a
reduction in road-trafﬁc fatalities, a decrease in exposure
to hazardous working conditions and other causes [12–15].
Nevertheless, compared with wealthier groups, the health
of population groups particularly hard hit in economic
terms is likely to suffer potentially leading to wide health
inequities. Economic shocks, whether positive or negative,
have in the past often been associated with increased rates
of common mental health problems as well as suicidal
behaviour [15].
Quantifying the health effects of the crisis is difﬁcult
for many reasons, not least the delay or lack in collecting
data on the health status from a number of European
Union countries. For each argument of the present com-
mentary we tried to provide a link between crisis and
consequence on health. However, there is also a com-
ponent of interpretation and opinion that supports each
reference. We  also acknowledge the difﬁculty of sayingy 113 (2013) 13– 19
with certainly how responses to the crisis have affected
health systems. Nevertheless, the paper seeks to contribute
towards a better understanding of the importance of health
policies within the European Union during the current
crisis.
2. The response of European health systems to
austerity
Reductions in public spending on health were achieved
through different measures throughout the European
Union. In countries such as Greece, which have been
hardest hit, the budget for health programmes has faced
real-term cuts. In this country public health expenditure
was  reduced from 9.8% of the GDP pre-crisis to 6% of
GDP post-crisis, inducing more than 100 Greek academics
and medics to sign a public letter to Greek politicians
expressing their serious concerns [16]. Several countries
including Ireland, Romania, Slovenia and the United King-
dom (UK) have frozen or reduced wages, and/or have
cut or not replaced posts [17]. Increasing user charges
has been another way  in which to meet the challenge
of austerity. Some Member States instituted or increased
user charges for households. For example, in Portugal,
user charges roughly doubled (including fees at emergency
departments) [18]. They are the most signiﬁcant source of
support for health expenditure beyond taxes and/or social
insurance [3]. However these charges are often criticised
because their potential for cost saving and increasing efﬁ-
ciency appears limited [19]. In addition a huge collection of
literature suggests that individuals’ disposition to seek care
may  decline when these individuals have reduced ﬁnancial
resources to pay for it [20–22]. Evidence from develop-
ing countries is paradigmatic at this regard [23]. While is
not possible to predict long-term consequences in reduc-
tions of medical care, today’s penny-pinching might lead
to tomorrow’s undetected illness [24].
The economic downturn has also acted as a catalyst for
structural reform, such as the closure or merger of hospitals
and a greater focus on outpatient and primary care. In Italy
the number of hospital beds fell to 4.1 per 1000 in 2010,
below the European average of 5.5 per 1000 inhabitants
[25]. However, a reduction in beds needs to be matched by
adequate investment in the infrastructure for public health,
health promotion, and primary care services. This comes at
a time when Italy is also facing the risk of a major reduction
in investments for preventive medicine, infrastructures,
and health information systems [26,27]. In addition, due
to the signiﬁcant contribution of pharmaceuticals to total
health expenditure (25% in Greece (2007), 21% in Portugal
(2008) and 17% in Ireland (2009)) [28,29], the pharmaceu-
tical sector was asked to contribute to the effort to reduce
costs in some countries. Measures observed include reduc-
tions in prices paid to manufacturers, as well as changes in
co-payments, distribution margins and VAT rates [30].
3. The consequence for healthLooking to previous international economic crises (for
example the Great Depression in 1929, the collapse of the
Soviet Union in 1991, the South East Asian ﬁnancial crisis
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n the late 1990s, etc.), can be useful for understanding
he public health effects of this crisis, and for anticipating
r mitigating the consequences [31–34]. Nevertheless, it
s not so easy to learn from previous crises [35], because
ach crisis was different and the public health effects
f economic downturns depend on several key issues.
uch as the scale of the crisis, the nature of government
esponses, the pre-existing conditions before the crisis, the
xtent to which populations are exposed, among others
17]. Despite these limitations, a range of existing studies
ave examined the impact of this recession in Europe and
ound a series of negative effects.
Consequences for health and health care in Greece are
ell described by Ifanti and Colleagues in this issue of the
ournal [36]. However, problems are also common in other
uropean countries. In the UK for example, the number
f people self-reporting ‘bad’ or ‘very bad’ health rose by
.8% between July 2009 and December 2010 [37]. Unem-
loyment can often increase anxiety and stress-related
onditions [38]. In Spain, the rates of people seeking pri-
ary care in hospitals for mood, anxiety, somatoform,
nd alcohol-related disorders rose during the recession-
ry period. About one third of this increased risk could be
ttributed to the threat of unemployment and/or housing
oreclosure [39]. Reports from Italy, the UK and some other
uropean countries, have observed that, there has been a
eversal of the downward trend in the suicide rate con-
urrent with increasing unemployment [40–44]. However,
aution should be exercised when looking at suicide data,
oth because of the time lag between recessionary events
nd the publication of ofﬁcial suicide data, and secondly
ecause some of the countries most affected by the crisis
uch as Spain have seen a fall in their suicide rates since
009 [45], while overall rates in Ireland have also changed
ittle [46]. Suicidal event data can act as a barometer for the
risis. It is, however, a very blunt instrument that only rep-
esents the tip of the iceberg. It probably underestimates
he broader mental health crisis linked to increased rates
f stress, anxiety and depression among populations who
re most vulnerable to economic volatility.
Rising incidence rates among some communicable dis-
ases have also been observed during the current recession.
 cross-national review suggested that economic crises
orsen infectious disease outcomes [47]. During the last
 years for example, Greece has been suffering from a high
urden of different large-scale epidemics. Between 2007
nd 2010, 10–15 new HIV infections were reported yearly
mong injecting drug users; this number increased to 256
n 2011, and to 314 in the ﬁrst 8 months of 2012 [48,49].
n increase of new HIV infections in this population was
lso reported in 2011 in Romania. While reporting 3 to 5
ases annually from 2007 to 2009, HIV infections among
njecting drug users increased to 12 cases in 2010 and to 62
ases in 2011. While in 2011, 15% (62/405) of the reported
IV infections were found among them, this had been only
% (12/440) in 2010 and 1% (5/428) in 2009 [50]. Addi-
ional reports on the health situation showed a decline in
ther health conditions. Stillbirth rates in Greece continu-
usly decreased over 42 years, from 16.03/1000 live births
n 1966 to a low of 3.31/1000 in 2008. In 2009–2010, this
hanged dramatically. The stillbirth rate increased to 4.28y 113 (2013) 13– 19 15
in 2009 and 4.36 in 2010 – an increase of 32% between 2008
and 2010 [51]. In northern Italy, rates of ﬁrst admission for
heart attack increased dramatically in 2011, one possible
consequence of the stress related to the crisis [52].
The health effects of the ﬁnancial crisis also concern
other areas not routinely associated with healthcare, such
as alcohol abuse, homicide, and road trafﬁc accidents.
Recessionary periods across the European Union Mem-
ber States between 1970 and 2007, show that a 1% rise
in the unemployment rate is associated with a 0.79% rise
in the homicide rate. Most strikingly, a 3% rise in the
unemployment rate was associated with a 28% increase in
deaths from alcohol abuse [53]. In the last six years, unem-
ployment increased substantially in many European Union
Member States, suggesting that similar effects might be
observed during this crisis as well as prior crises. In con-
trast, past recessions have been associated with a reduction
in road trafﬁc accidents and increases in physical activity
due to the costs of transportation. Such recessions have also
potentially increased time spent with family and friends.
In the current downturn for instance road trafﬁc fatalities
have continued to fall in all EU countries [54], but it will be
difﬁcult to determine whether there will be any long term
impacts associated with any changes in physical activities.
4. Austerity: a window for promotion, prevention
and innovation?
The promotion of good health and wellbeing are essen-
tial elements of all health systems; poor health and
wellbeing has consequences that go well beyond the health
system and have wider negative impacts on the econ-
omy. This is particularly true because evidence from some
past economic shocks suggests that these adverse impacts
can be long lasting [55]. Despite the importance of health
promotion, countries do not appear to spend much on pre-
vention from within their health care budgets. Cyclically,
when health care budgets have been under pressure, health
promotion and public health have been among the ﬁrst
areas where cuts have been made. On average health pro-
motion and disease prevention accounted for just 3% of
health care expenditure in OECD EU countries in 2010 [2],
although it is important to recognise that many health pro-
moting actions take place outside of the health sector (such
as in kindergartens, schools, workplaces and the housing
system). Pressure on budgets is not conﬁned to health sys-
tems alone and some European countries have had to make
substantial reductions in some areas of public expenditure
which may  also increase risks to health [56]. It is therefore
vital to both strengthen and make use of existing evidence
on the cost effectiveness of measures to alleviate the impact
of economic shocks on health.
The aforementioned increased risks to physical and
mental wellbeing at times of economic crisis further
emphasise the importance of careful investment in cost
effective interventions. The most immediate impacts of
economic shocks are on psychological wellbeing, risks of
suicidal behaviour and inter-personal violence. Many cost
effective actions to protect mental health can be imple-
mented outside the health care system [57]. But also
socio-economic health risk factors related to poverty, such
lth Polic16 G. Quaglio et al. / Hea
as food-related or housing conditions, are critical at a time
of economic recession, and require attention to promote
and protect health. Different approaches will be required
in different countries depending on resources available and
populations that are most at risk. One key area concerns
active labour market programmes which help people to
stay in work or provide support to help them re-enter
the labour market [58,59]. Not only do these active labour
market programmes provide health assets and bolster
resilience but they can also promote economic growth
[58]. Combinations of different interventions, including tax
reforms, as well as restrictions on sales and advertising, can
be cost effective in tackling harmful alcohol use, including
binge drinking and inter-personal violence, across Europe
[60]. Another area with evidence on long-term cost effec-
tiveness concerns continued investment in interventions
at an early age, both to support families that may  be in
stress due to their socio-economic circumstances, as well
as measures to promote the emotional health and resilience
of children and adolescents [60,61].
The timely availability of data is particularly relevant
when health authorities are asked to react quickly and
yet relevant health data has often been published 2 years
behind other ﬁnancial accounts [62]. This particularly con-
cerns trends in suicides where data from 2010 to 2011
are only now becoming available in many countries. There
may  be scope for better information ﬂows at the European
level, analyzing the phenomena on which the crisis may
exert major effects. It is also the case that the crisis has had
different effects on health in different countries; it is impor-
tant to better understand what protective factors may  be
in place and have a ﬂexible approach to action, as required
in different contexts.
The current economic climate while challenging,
presents opportunities for restructuring interventions over
the long term. Ways to reduce inappropriate care need
to be better implemented. For example avoiding unnec-
essary hospital admissions and shortening hospital stays is
becoming a priority [63]. Hospitalisations due to uncon-
trolled diabetes are too high throughout Europe [3].
Chronic obstructive pulmonary diseases are preventable
or may  be managed by preventive interventions, avoiding
hospitalisation [64]. Alternatives to conventional hospital-
isation include day centres [65,66], quick diagnosis units
[67], hospital at home [68] and, in some circumstances,
tele-monitoring [69]. These measures, when accurately
utilised, not only may  reduce costs, but also increase
patient comfort and improve efﬁciency. Better use of lab-
oratory tests can be encouraged. A recent study from Italy
showed that an appropriate use of pathology-speciﬁc lab-
oratory proﬁles (a battery of tests) can decrease total pre-
scriptions, suggesting a more appropriate use of tests and a
better allocation of resources [70]. Roughly 30% of the out-
patient laboratory tests are ordered without a deﬁnite diag-
nosis (“just to check, to reassure the patients, or because
lab tests should be done at least once a year”, etc.) [70–72].
Inappropriate medication prescriptions is another possible
area of intervention: approximately one in ﬁve prescrip-
tions to older people in primary care is inappropriate [73].
As already mentioned, some countries used the crisis to
cut costs in the pharmaceutical sector, strengthening theiry 113 (2013) 13– 19
position in price negotiations with pharmaceutical com-
panies. This needs to be pursued. However, in this sector
more could be promoted. For example it is hard to explain
the reasons in this time of crisis for observed delays in the
entry of generic medicines to the market or why  the cost of
drugs purchased by hospitals could be much different from
hospital to hospital even within the same country [74].
There are also opportunities to think about health issues
more holistically, recognising that the costs and beneﬁts
of actions go across many sectors. Addressing these issues
from a sector speciﬁc perspective leads to missed oppor-
tunities for the implementation of effective actions. For
instance, there are opportunities for innovative approaches
to protecting health outside the health sector, such as
investing in measures to reduce the risks of unmanageable
debt [75]. Measures, including ﬁnancial advice from non-
commercial organisations to help individuals deal with
problem debt, can improve mental health outcomes [76].
Within the health system as well, the current economic
downturn could bring together clinical medicine and pub-
lic health in more mutually beneﬁcial ways that could
improve health and allow for more efﬁcient health system
spending [77]. In doing all of this however, it is important
to determine efﬁciency and cost effectiveness. Therefore,
cooperation between European countries is essential: it
allows synergies and benchmarking and provides proper
evidence for action, in identifying best practice cases, which
can be transposed and adapted to different systems.
5. Conclusions
The on-going ﬁnancial and economic crisis impacts
health in a variety of ways. Primarily, factors which deter-
mine health but also socio-economic status could support
population health and social wellbeing [19]. On one hand,
health professionals and those responsible for health man-
agement systems need to be more proactive with new
innovative approaches, for example reducing inappropri-
ate admissions and stays, based on careful analysis of data
and causes of inappropriateness. In addition, scientists and
experts in public health should also be able to promote an
evidence-based approach to economic and public health
recovery, analyzing past successes and failures [78]. Atten-
tion must be paid to the new EU Framework programme for
research and innovation 2014–2020 (Horizon 2020) as it
appears that health research questions concerning, among
others, the quality and safety of health care, the ﬁnancial
feasibility, and productivity of health systems are failing
the test of attention within this new framework [79].
On the other hand, policy makers need to be well aware
that these interventions need to be assessed in the light
of health systems objectives. Historical evidence suggests
that in times of economic crisis, policies of cutbacks can
further jeopardise population health [47,80]. At the same
time they have to be conscious of the consequences for
health outcomes and the importance of investing in health
to boost the economy. During the present economic cri-
sis, there are examples of European governments whose
health policies try to guarantee standard of their health
system. These include policies which try to maintain pub-
lic funding for the health system, raising contributions
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nd broadening the revenue base, (as in the Netherlands),
r targeting to protect people with low incomes (as in
ortugal). In other cases policies provide major impetus
n enhancing efﬁcacy, strengthening pharmaceutical pol-
cy (Austria, France, Greece), consolidating primary care
ccess and quality (Italy, UK, Lithuania), restructuring the
ealth system (Denmark, Bulgaria, Spain), and encouraging
 cost-effective investment in health goods, services and
echnologies (UK, Belgium, Portugal) [81].
Healthcare is frequently represented only as a drain of
esources, but it can represent a sector which would drive
conomic growth [82–84]. As one of the largest service
ndustries, the health sector represents one of the most
mportant sectors in developed economies. Currently its
utput accounts for about 9% of GDP in the EU-28, and
round 10% of all workers in the European Union belong
o the health and welfare sector. Through efﬁciency in pro-
uctivity the health sector, could have an important impact
n performance measures in economies as a whole [83,85].
he disease burden in developed countries is mainly driven
y lifestyle-related factors, and consequently, health, edu-
ation, and cultural factors are closely related. Therefore,
ealth investment should involve measures addressing
ssues outside the inﬂuence of the traditional healthcare
ystems [83].
There is growing evidence that negative impacts on
ealth can be moderated by appropriate investment in
ocial protection, public health and health promotion, in
ddition to healthcare provision. While there is a consensus
hat data and evidence should underpin the formulation
f austerity policies, it is governance and leadership that
ill mostly determine how well health systems are pre-
ared to face the crisis and ﬁnd ways to mitigate its
ffects. However what we should not permit in the Euro-
ean Union is that inequity in access to health services
arked deep inequalities in health outcomes [86]. It could
epresent an additional element of discrimination and
nacceptable difference among European Union Member
tates.
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